FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 313:1322-1326 November 21, 1985 Number 21 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We identified eight patients with the lupus anticoagulant (an autoantibody acquired by some patients with systemic lupus erythematosus), by observation of an increased activated partial thromboplastin time and abnormal results on a tissue thromboplastin-inhibition test. The patients had experienced a total of 30 spontaneous abortions and fetal deaths in 31 previous pregnancies (96.8 per cent). During their next pregnancy, the patients were treated with 40 to 50 mg of prednisone per day and 81 mg of aspirin per day. The therapy shortened their activated partial thromboplastin times, produced normal values for tissue thromboplastin inhibition, and reduced the rate of pregnancy loss to 37.5 per cent. However, preeclampsia developed in the five patients who gave birth to live infants, and fetal growth retardation occurred in three cases. The corticosteroid and low-dose aspirin regimen appears to improve perinatal outcome in cases in which the mother has the lupus anticoagulant, but such practices as careful fetal surveillance and preterm delivery when appropriate are also important to successful obstetric management of such cases.

This article has been cited by other articles:

• Parke, A (2006). Drug exposure, pregnancy outcome and fetal and childhood development occurring in the offspring of mothers with systemic lupus erythematosus and other chronic autoimmune diseases. Lupus 15: 808-813 [Abstract]  
• Parke, A (2004). Short and long-term maternal outcomes in patients with phospholipid antibodies. Lupus 13: 703-704 [Abstract]  
• Stone, S, Khamashta, M A, Poston, L (2001). Placentation, antiphospholipid syndrome and pregnancy outcome. Lupus 10: 67-74 [Abstract]  
• Macik, B. G., Rand, J. H., Konkle, B. A. (2001). Thrombophilia: What's a Practitioner to Do?. ASH Education Book 2001: 322-338 [Abstract] [Full Text]  
• Cohen, S. B., Goldenberg, M., Rabinovici, J., Lidor, A. L., Dulitzky, M., Gilburd, B., Shoenfeld, Y., Schiff, E. (2000). Anti-cardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the anti-phospholipid syndrome. Hum Reprod 15: 1170-1172 [Abstract] [Full Text]  
• Takakuwa, K., Honda, K., Ishii, K., Hataya, I., Yasuda, M., Tanaka, K. (1999). Studies on the HLA-DRB1 genotypes in Japanese women with severe pre-eclampsia positive and negative for anticardiolipin antibody using a polymerase chain reaction-restriction fragment length polymorphism method. Hum Reprod 14: 2980-2986 [Abstract] [Full Text]  
• Mavragani, C. P., Ioannidis, J. P. A., Tzioufas, A. G., Hantoumi, I. E., Moutsopoulos, H. M. (1999). Recurrent pregnancy loss and autoantibody profile in autoimmune diseases. Rheumatology (Oxford) 38: 1228-1233 [Abstract] [Full Text]  
• Hill, J. A. (1997). Immunotherapy for Recurrent Pregnancy Loss: "Standard of Care of Buyer Beware". Reproductive Sciences 4: 267-273  
• Lakasing, L., Poston, L. (1997). Adverse pregnancy outcome in the antiphospholipid syndrome: focus for future research. Lupus 6: 681-684 [Abstract]  
• Toglia, M. R., Weg, J. G. (1996). Venous Thromboembolism during Pregnancy. NEJM 335: 108-114 [Full Text]  
• Katano, K., Aoki, K., Ogasawara, M., Sasa, H., Hayashi, Y., Kawamura, M., Yagami, Y. (1995). Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera. Lupus 4: 304-308 [Abstract]  
• Shoenfeld, Y., Blank, M. (1994). Effect of Long-Acting Thromboxane Receptor Antagonist (BMS 180,291) on Experimental Antiphospholipid Syndrome. Lupus 3: 397-400 [Abstract]  
• Branch, D. W. (1994). Thoughts on the Mechanism of Pregnancy Loss Associated with the Antiphospholipid Syndrome. Lupus 3: 275-280  
• Barbui, T., Finazzi, G. (1994). Clinical Trials on Antiphospholipid Syndrome: What is Being Done and What is Needed?. Lupus 3: 303-307  
• Ames, P., Khamashta, M., Hughes, G. (1994). Clinical and therapeutic aspects of the antiphospholipid syndrome. Lupus 4: S23-S25  
• Rossi, E., Costa, M. (1993). Fish Oil Derivatives as a Prophylaxis of Recurrent Miscarriage Associated with Antiphospholipid Antibodies (APL) : a Pilot Study. Lupus 2: 319-323 [Abstract]  
• Millan-Mon, A., Porto, J.L., Novo, C., Garcia-Martin, C., Guitian, D. (1993). Hepatic Infarction in a Pregnant Patient with the 'Primary' Antiphospholipid Syndrome. Lupus 2: 275-279 [Abstract]  
• Millan-Mon, A., Porto, J.L., Novo, C., Garcia-Martin, C., Guitian, D. (1993). Hepatic Infarction in a Pregnant Patient with the 'Primary' Antiphospholipid Syndrome. Lupus 2: 275-279 [Abstract]  
• Rosove, M. H., Brewer, P. M. C. (1992). Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients. ANN INTERN MED 117: 303-308 [Abstract]  
• Ichikawa, K., Suzuki, T., Hashimoto, Y., Sumida, T., Tomioka, H., Yoshida, S., Koike, T. (1992). Monoclonal Autoantibodies to Cardiolipin Derived from SLE Mice. Lupus 1: 239-247 [Abstract]  
• Fonseca, E., Alvarez, R., Gonzalez, M.R., Pascual, D. (1992). Prevalence of Anticardiolipin Antibodies in Subacute Cutaneous Lupus Erythematosus. Lupus 1: 265-268 [Abstract]  
• Stagnaro-Green, A., Roman, S. H., Cobin, R. H., El-Harazy, E., Alvarez-Marfany, M., Davies, T. F. (1990). Detection of At-Risk Pregnancy by Means of Highly Sensitive Assays for Thyroid Autoantibodies. JAMA 264: 1422-1425 [Abstract]  
• Smith, K. J., Skelton, H. G. III, James, W. D., Angritt, P., Scherbenske, J., Vaughan, C. K., Lupton, G. P. (1990). Cutaneous Histopathologic Findings in `Antiphospholipid Syndrome' Correlation With Disease, Including Human Immunodeficiency Virus Disease. Arch Dermatol 126: 1176-1183 [Abstract]  
• Love, P. E., Santoro, S. A. (1990). Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders: Prevalence and Clinical Significance. ANN INTERN MED 112: 682-698 [Abstract]  
• Parke, A., Maier, D., Wilson, D., Andreoli, J., Ballow, M. (1989). Intravenous Gamma-Globulin, Antiphospholipid Antibodies, and Pregnancy. ANN INTERN MED 110: 495-496 [Abstract]  
• Francois, A., Freund, M., Daffos, F., Remy, P., Aiach, M., Jacquot, C. (1988). Repeated Fetal Losses and the Lupus Anticoagulant. ANN INTERN MED 109: 993-994 [Abstract]  
• Stafford-Brady, F. J., Gladman, D. D., Urowitz, M. B. (1988). Successful Pregnancy in Systemic Lupus Erythematosus With an Untreated Lupus Anticoagulant. Arch Intern Med 148: 1647-1648 [Abstract]  
• GOLBUS, J., FOX, D. A. (1987). The Lupus Anticoagulant: A Confusing Misnomer. ANN INTERN MED 106: 911-911 [Abstract]  
• PETRI, M., RHEINSCHMIDT, M., WHITING-O'KEEFE, Q., HELLMANN, D., CORASH, L. (1987). The Frequency of Lupus Anticoagulant in Systemic Lupus Erythematosus: A Study of Sixty Consecutive Patients by Activated Partial Thromboplastin Time, Russell Viper Venom Time, and Anticardiolipin Antibody Level. ANN INTERN MED 106: 524-531 [Abstract]  
• Greenspoon, J. S. (1986). Cerebral Infarction, Lupus Anticoagulant, and Habitual Abortion. JAMA 255: 2164-2164 [Abstract]